Gaurav Shah, Rocket Pharma CEO

Rock­et Phar­ma­ceu­ti­cals says FDA agrees to 12-pa­tient study for ac­cel­er­at­ed ap­proval, ex­pects to raise $175M

Rock­et Phar­ma­ceu­ti­cals an­nounced Wednes­day that it ex­pects to raise $175 mil­lion from a stock sale, a day af­ter …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.